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Matrix metalloproteases promote tumor cell invasion, epithelial-to-mesenchymal transitions, and metasta-
ses, but whether they directly regulate stem cells is unknown. In this issue of Cell Stem Cell, Kessenbrock
et al. (2013) now show that MMP3, independent of its proteolytic activity, regulates murine mammary stem
cells by sequestering noncanonical Wnt signaling ligands, which has implications for breast cancer patho-
genesis.Matrix metalloproteases (MMPs) have
numerous functions at the cellular and
tissue level, in both physiological and
pathophysiological states. MMPs contain
protein binding hemopexin (HPX) and
transmembrane domains and a catalytic
domain that is activated by proteolytic
cleavage of a propeptide. Stromelysin-1/
MMP3, an MMP expressed mainly in the
stroma, is best known for its role in has-
tening tumor progression by destroying
basement membranes via its catalytic
domain. Unbridled MMP3 activity causes
murine epithelial cells to undergo epithe-
lial-to-mesenchymal transitions (EMTs)
and promotes genomic instability (Radi-
sky et al., 2005) at the cellular level, and
at the tissue-level, aberrantMMP3 activity
in the mammary gland stimulates tumori-
genesis (Sternlicht et al., 1999). Mammary
gland stem cells express constellations of
genes consistent with EMT, a determinant
of the stem cell phenotype (Mani et al.,
2008), and share other phenotypic simi-
larities with putative breast cancer stem
cells, which are thought to drive tumor for-
mation. Tightly controlled canonical Wnt
signaling is synonymous with stem cell
homeostasis, whereas unregulated Wnt
signaling causes mammary tumors in
mice (Alexander et al., 2012). Thus MMP
activity and Wnt signaling can promote
similar biological outcomes and could
be functionally intertwined, but evidence
supporting this link has been lacking until
now. In this issue of Cell Stem Cell, Zena
Werb and colleagues demonstrate that
MMP3 regulates murine mammary stem
cell activity through an unexpectedmech-
anism: the noncatalytic HPX domain of
MMP3 binds to and inactivates the non-
canonical Wnt ligand Wnt5b, resulting inpromotion of mammary stem cell activa-
tion through the canonical Wnt pathway
(Kessenbrock et al., 2013).
Kessenbrock et al. set out to gain a
better understanding of the mechanism
through which overexpression of MMP3
in transgenic models induced mammary
tumors (Sternlicht et al., 1999). To do so,
they utilized lentiviruses to transduce
primary mammary epithelial cells (MECs)
with secreted versions of a full length
furin-activateable MMP3 (MMP3-FL), a
proteolytically inactive mutant, or the
MMP3-HPX domain by itself. Transduced
MECs were then implanted into cleared
mammary fat pads, where mammary
epithelia can undergo extensive morpho-
genesis. MECs potentially give rise to
functional mammary glands or to various
stages of pathology depending on the
genotype of both the implanted cells and
the stroma. MMP3-FL transduced MECs
gave rise to hyperbranching epithelial out-
growths, consistent with previous reports
inMMP3 transgenic mice (Sternlicht et al.,
1999). Surprisingly, both the proteolyti-
cally inactive mutant and the HPX domain
alone gave rise to an identical hyper-
branching phenotype. The authors further
showed that the HPX domain of MMP10,
though highly homologous to the MMP3
HPX, had no effect on gland morphology,
thus demonstrating a specialized function
of the MMP3-HPX domain.
Kessenbrock et al. then identified bind-
ing targets of MMP3-HPX that could
explain this outgrowth phenotype. Yeast
two-hybrid analysis using MMP3-HPX
as bait identified 21 proteins, including
the extracellular noncanonical Wnt ligand
Wnt5b, as potential candidates. The
MMP3-HPX/Wnt5b interaction was spe-Cell Stem Cell 13, Scific because HPX domains from mam-
mary MMPs 2, 10, and 14 did not interact
with Wnt5b, and MMP3-HPX did not
interact with other mammary Wnts 2, 4,
6, 7b, or 10b. Using a version of Wnt5b
with tagged C and N termini, the authors
showed that Wnt5b is a bona fide cleav-
age substrate of MMP3, as well as a bind-
ing target of the HPX domain. ThusMMP3
dually antagonizes Wnt5b by interfering
with receptor binding and by irreversible
proteolysis. This two-pronged inhibitory
approach requires relatively few mole-
cules of MMP3 in order to antagonize
Wnt5b.
Kessenbrock et al. next assessed the
phenotypic consequences of the MMP3/
Wnt5b interaction and how Wnt5b might
mediate these effects. Overexpression
of Wnt5b in MECs suppressed branch-
ing and mammary epithelial outgrowths.
Wnts are known to signal either in a
canonical fashion that results in nuclear
localization of b-catenin or in a noncanon-
ical fashion via nuclear factor of activated
T cells (NFAT) (Alexander et al., 2012).
Wnt5b overexpression caused the accu-
mulation of NFAT in MECs, consistent
with noncanonical signaling, which was
antagonized by addition of MMP3-FL.
Conversely, either MMP3-FL or Wnt1
overexpression caused the hyperbranch-
ing phenotype, which was accompanied
by a striking increase in nuclear b-catenin
and expression of the Wnt responsive
gene Axin2, consistent with activation
of canonical Wnt signaling. Thus when
MMP3 activity was high, Wnt5b was inac-
tivated and the canonical Wnt pathway
was activated by one of the several
mammary-resident Wnts. When MMP3
was not overexpressed, intact Wnt5beptember 5, 2013 ª2013 Elsevier Inc. 259
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pathway. The exact mechanism by which
Wnt5b suppresses the canonical pathway
is unknown, but may involve competition
for the frizzled coreceptors (Grumolato
et al., 2010).
The authors then provided direct evi-
dence that MMP3 modulates mammary
stem cell activity. They showed that
MMP3-overexpressing MECs had an
expanded CD24/CD49fhi stem-cell-en-
riched fraction, and they produced more
mammospheres in culture compared to
control MECs. Increased mammosphere
production from MMP3-FL MECs was
prevented by addition of the tankyrase
inhibitor JW-55, which blocks canonical
Wnt signaling. Conversely, MMP3 null
mice exhibited decreased numbers of
stem cells and produced half as many
mammospheres. Both of these pheno-
types were reversed by addition of
canonical Wnt3a. The authors performed
mammary fat pad reconstitution assays
to demonstrate that regenerative capacity
of mammary epithelia from MMP3 null
mice was reduced 7-fold compared to
epithelia from control mice. Thus Kessen-
brock et al. provide an elegantmechanism
for control ofmammary stem cells inmice,
showing that MMP3 sequesters Wnt5b
and promotes stem cell activity by allow-
ing canonical Wnt signaling to proceed
(Kessenbrock et al., 2013). Accordingly,
the patterns of MMP3 and Wnt5b expres-
sion in mammary gland are complemen-
tary to known developmental stage-
specific stem cell requirements: MMP3
levels increase from early to midpreg-260 Cell Stem Cell 13, September 5, 2013 ª2nancy as the epithelia expands as much
as 10-fold to prepare for lactation, then
completely disappears as Wnt5b reaches
its highest levels just before lactation
begins (Gavin and McMahon, 1992; Sor-
rell et al., 2005). MMP3 also is highly
expressed during mammary gland involu-
tion, which is perplexing in the present
context and suggests that mechanisms
exist to compartmentalize MMP3 activity
into either roles that regulate mammary
stem cell behavior or roles that play a
purely proteolytic function.
Even in normal, nontransformed MECs,
the principal phenotypes reported in
conjunction with overexpressed MMP3
or canonical Wnts were consistent
with abnormal hyperplastic pathologies.
Another study recently demonstrated
that MMP3-HPX binds to a secreted
form of HSP90b, causing the hyper-
branching morphology to emerge in
MECs embedded in organotypic 3D cul-
tures (Correia et al., 2013). Beyond
Wnt5b, Kessenbrock et al. and others
identified a number of MMP3-HPX targets
that will need to be studied in greater
detail for us to fully understand the extent
of this molecule’s functional pleiotropy.
When viewed from a broader perspective,
these studies may help connect changes
in the stromal microenvironment to
behavior that is often associated with
cancer stem cell activity. Tumor micro-
environments are known to possess
numerous factors capable of inducing
EMT gene programs, such as MMP3,
which could possibly impose cancer
stem-cell-like states (LaBarge, 2010).013 Elsevier Inc.Thus MMPs may be the perfect fuel for
tumor progression because they not only
destroy the basement membrane respon-
sible for providing polarity cues, but they
also may indirectly drive the stem-cell-
like states thought to be synonymous
with invasion and metastasis.REFERENCES
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